BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3126346)

  • 1. Relationships between structure and function of tissue-type plasminogen activator.
    Rijken DC
    Klin Wochenschr; 1988; 66 Suppl 12():33-9. PubMed ID: 3126346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and function of human tissue-type plasminogen activator (t-PA).
    van Zonneveld AJ; Veerman H; MacDonald ME; van Mourik JA; Pannekoek H
    J Cell Biochem; 1986; 32(3):169-78. PubMed ID: 3097031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of molecular variants of tissue-type plasminogen activator.
    Krause J; Tanswell P
    Arzneimittelforschung; 1989 May; 39(5):632-7. PubMed ID: 2502992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
    Anglés-Cano E; Rojas G
    Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.
    Lamba D; Bauer M; Huber R; Fischer S; Rudolph R; Kohnert U; Bode W
    J Mol Biol; 1996 Apr; 258(1):117-35. PubMed ID: 8613982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
    Boutaud A; Castellino FJ
    Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.
    Renatus M; Engh RA; Stubbs MT; Huber R; Fischer S; Kohnert U; Bode W
    EMBO J; 1997 Aug; 16(16):4797-805. PubMed ID: 9305622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic domain structure of vampire bat plasminogen activator: a molecular paradigm for proteolysis without activation cleavage.
    Renatus M; Stubbs MT; Huber R; Bringmann P; Donner P; Schleuning WD; Bode W
    Biochemistry; 1997 Nov; 36(44):13483-93. PubMed ID: 9354616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexation of the tissue plasminogen activator protease with benzamidine-type inhibitors: interference by the kringle 2 module.
    Hu CK; Kohnert U; Sturzebecher J; Fischer S; Llinas M
    Biochemistry; 1996 Mar; 35(10):3270-6. PubMed ID: 8605163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion protein stimulates tissue-type plasminogen activator-mediated plasmin generation via a lysine-binding site on kringle 2.
    Epple G; Schleuning WD; Kettelgerdes G; Kottgen E; Gessner R; Praus M
    J Thromb Haemost; 2004 Jun; 2(6):962-8. PubMed ID: 15140132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
    Jankun J; Skrzypczak-Jankun E
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):109-23. PubMed ID: 10738907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial orientation of tissue-type plasminogen activator bound at the melanoma cell surface.
    Bizik J; Trancikova D; Felnerova D; Verheijen JH; Vaheri A
    Biochem Biophys Res Commun; 1997 Oct; 239(1):322-8. PubMed ID: 9345318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen and fibrin structure and functions.
    Mosesson MW
    J Thromb Haemost; 2005 Aug; 3(8):1894-904. PubMed ID: 16102057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional effects of kringle 2 glycosylation in a hybrid plasminogen activator.
    Asselbergs FA; Bürgi R; van Oostrum J
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):27-33. PubMed ID: 8384498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kringle-containing protease with plasminogen-like activity in the basal chordate Branchiostoma belcheri.
    Liu M; Zhang S
    Biosci Rep; 2009 Sep; 29(6):385-95. PubMed ID: 19193194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tissue-type plasminogen activator (T-PA). Structure and function].
    Pietrucha T; Cierniewski CS
    Acta Haematol Pol; 1992; 23(3):157-64. PubMed ID: 1492540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomous functions of structural domains on human tissue-type plasminogen activator.
    van Zonneveld AJ; Veerman H; Pannekoek H
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4670-4. PubMed ID: 3088564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
    Donate LE; Gherardi E; Srinivasan N; Sowdhamini R; Aparicio S; Blundell TL
    Protein Sci; 1994 Dec; 3(12):2378-94. PubMed ID: 7756992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.